Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, February 26, 2021
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
[ Fri, Feb 26th 2021
] - WOPRAI
Etzer Darout Initiated (AKRO) at Strong Buy and Held Target at $54 on, Feb 26th, 2021
Etzer Darout of Guggenheim, Initiated "Akero Therapeutics, Inc." (AKRO) at Strong Buy and Held Target at $54 on, Feb 26th, 2021.
Etzer has made no other calls on AKRO in the last 4 months.
There is 1 other peer that has a rating on AKRO. Out of the 1 peers that are also analyzing AKRO, 0 agree with Etzer's Rating of Hold.
This is the rating of the analyst that currently disagrees with Etzer
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $64 on, Friday, November 13th, 2020
